Cancer Clinical Trial
Official title:
Programa Online de intervenção Cognitivo-Comportamental Para o Tratamento da Insónia em Sobreviventes Oncológicos
Verified date | March 2024 |
Source | University of Coimbra |
Contact | Maria Clara |
Phone | +351 911820289 |
mclara[@]uc.pt | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main purpose of this study is to determine the treatment effects, feasibility, and acceptability of an internet-based cognitive-behavioral therapy intervention to improve the sleep of Portuguese cancer survivors with insomnia.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 2024 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age 18+ years - Provided informed consent - Ability to read and write in Portuguese - Ability to use a computer and/or smartphone, and the internet - History of cancer - Have completed primary cancer treatment (survivors who are on hormone and/or other long-term maintenance therapy agencies are eligible to participate) - Subclinical or significant symptoms of insomnia (ISI scores>8) - Ongoing sleep medication accepted if the dosage has been stable during the last 3 months - No participation in any other interventional study or clinical trial Exclusion Criteria: - Age = 18 years - Absence of clinically or subclinical significant symptoms - No history of cancer - Inability to provide informed consent - Inability to use a computer and/or smartphone - No access to the internet - Another untreated sleep diagnosis - Current major psychiatric or medical condition - Pregnancy or breastfeeding - Parallel ongoing psychological treatment for insomnia - Habitual night shift, or rotating shift-workers |
Country | Name | City | State |
---|---|---|---|
Portugal | Center for Research in Neuropsychology and Cognitive and Behavioral Intervention (CINEICC) | Coimbra |
Lead Sponsor | Collaborator |
---|---|
University of Coimbra |
Portugal,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Feasibility as assessed by recruitment, retention/attrition data | Computed as the number of participants that registered to enroll, dropped out before completing the intervention and completed the intervention | Post-intervention (8 weeks after enrollment) | |
Other | Feasibility as assessed by usage (program visit length, completion of activities) | Computed as the average duration of participants' visits to the intervention, sleep diary logs, homework activities | Post-intervention (8 weeks after enrollment) | |
Other | Acceptability | Self-report scales of satisfaction, adherence and perceived helpfulness rated on 4-point Likert scales adapted from Manber et al. (2011) | Post-intervention (8 weeks after enrollment) | |
Other | Usability | User Experience Questionnaire | Post-intervention (8 weeks after enrollment) | |
Primary | Insomnia severity | Insomnia Severity Index (overall score 0-28 interpreted as follows: 0-7 absence of insomnia; 8-14 sub-threshold insomnia; 15-21 moderate insomnia; 22-28 severe insomnia) | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Sleep efficiency | Sleep Diary | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Total sleep time | Sleep Diary | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Number of nocturnal awakenings | Sleep Diary | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Wake after sleep onset | Sleep Diary | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Sleep onset latency | Sleep Diary | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Cancer-related fatigue | Multidimensional Fatigue Symptom Inventory-Short Form (overall score 24-96, higher scores denote higher levels of cancer-related fatigue) | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Health-related quality of life | European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30; World Health Organization Quality of Life - Brief (overall scores 0-100, higher scores indicate higher quality of life) | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Anxiety | Hospital Anxiety and Depression Scale (total subscale 0-21, higher scores denote highest anxiety level) | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups | |
Secondary | Depression | Hospital Anxiety and Depression Scale (total subscale 0-21, higher scores denote highest depression level) | Changes from baseline to post-intervention (8 weeks after enrollment); 3- and 6- months follow-ups |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|